Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06012097

Impact of Gel Aromatherapy on Pain for Patients With De Quervain Disease

Impact of Gel Aromatherapy on Pain for Patients With De Quervain Disease : Monocentric Study, Controlled, Randomized, Partially Blinded, in Paralleled Groups

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
70 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

De Quervain disease is characterized by an adductor pollicis longus and extensor pollicis brevis tendons inflammation as thys pass beneath the extensor retinaculum at the radial styloid. This pathology is recognized as a musculoskeletal disorder of the upper limb triggering functional deficits resulting to possible modifications in the professional activity, sources of absenteeism, thus constituting an economic cost for society. At the etiological level, this pathology also affects young mothers (it's called "mother's wrist" or mommy thumb"), mobile phone users ("textonite", "Blackberryte") or video game players ("Nintendoite"). Currently, the treatment is mainly conservative by splint and anti-inflammatory gel and/or corticosteroid infiltration. Howewer, these therapies have undesirable effects. The interest of this study is therefore to propose another therapy based on aromatherapy gel.

Conditions

Interventions

TypeNameDescription
DRUGDiclofenac gelusing diclofenac as a comparator
DRUGAromatherapy gelusing Aromatherapy gel as an experimetnal treatment

Timeline

Start date
2024-06-04
Primary completion
2026-04-01
Completion
2026-04-01
First posted
2023-08-25
Last updated
2025-08-03

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06012097. Inclusion in this directory is not an endorsement.